P035 Defining Responders for the Crohn’s Disease Patient-Reported Outcomes Signs and Symptoms (CD-PRO/SS) Tool Using Data From Patients Treated With Etrolizumab
Higgins, Peter, DeBusk, Kendra, Jacob, Rhian, Hassanali, Azra, Sharafali, Zaineb, Oh, Young, Kadva, Alysha, Matsui, Alison
Published in The American journal of gastroenterology (01.12.2019)
Published in The American journal of gastroenterology (01.12.2019)
Get full text
Journal Article
Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease: Results from a Phase 1 Randomized Trial
Zhang, Wenhui, Scalori, Astrid, Fuh, Franklin, McBride, Jacqueline, She, Gaohong, Kierkus, Jaroslaw, Korczowski, Bartosz, Li, Regan, Abouhossein, Mariam, Kadva, Alysha, Park, K T, Tang, Meina Tao
Published in Inflammatory bowel diseases (03.10.2022)
Published in Inflammatory bowel diseases (03.10.2022)
Get full text
Journal Article
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Blanco, Ricardo, Kadva, Alysha, Dimonaco, Sophie
Published in Annals of the rheumatic diseases (01.07.2017)
Published in Annals of the rheumatic diseases (01.07.2017)
Get full text
Journal Article
Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease: Results from a Phase 1 Randomized Trial
Zhang, Wenhui, Scalori, Astrid, Fuh, Franklin, McBride, Jacqueline, She, Gaohong, Kierkus, Jaroslaw, Korczowksi, Bartosz, Li, Regan, Abouhossein, Mariam, Kadva, Alysha, Park, K T, Tang, Meina Tao
Published in Inflammatory bowel diseases (01.09.2022)
Published in Inflammatory bowel diseases (01.09.2022)
Get full text
Journal Article
Abstract P225: Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET : Update from the Phase 1 SHIELD-1 trial
Hong, David S., Catenacci, Daniel, Bazhenova, Lyudmila, Cho, Byoung Chul, Ponz-Sarvise, Mariano, Heist, Rebecca, Moreno, Victor, Falchook, Gerald, Zhu, Viola W., Swalduz, Aurélie, Besse, Benjamin, Kim, Dong-Wan, Yoon, Shinkyo, Le, Xiuning, Zhao, Tingting, Kadva, Alysha, Zimmerman, Zachary, Lee, Jeeyun
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
06. Identification of optimal subcutaneous doses of tocilizumab in children with polyarticular-course juvenile idiopathic arthritis
Jafri, Shazad, Ramanan, Athimalaipet V., De Benedetti, Fabrizio, Ruperto, Nicolino, Lovell, Daniel, Cuttica, Ruben, Weiss, Jennifer E., Henrickson, Michael, Schmeling, Heinrike, Anton, Jordi, Minden, Kirsten, Hsu, Joy, Bharucha, Kamal, Wimalasundera, Sunethra, Kadva, Alysha K., Upmanyu, Ruchi, Mallalieu, Navita L., Martini, Alberto, Brunner, Hermine
Published in Rheumatology (Oxford, England) (01.10.2017)
Published in Rheumatology (Oxford, England) (01.10.2017)
Get full text
Journal Article
A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study
Benedetti, Fabrizio, Ruperto, Nicolino, Brunner, Hermine, Grom, Alexei A., Wulffraat, Nico, Henrickson, Michael, Jerath, Rita, Kimura, Yuki, Kadva, Alysha K., Wang, Jianmei, Martini, Alberto, Lovell, Daniel J.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.03.2014)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.03.2014)
Get full text
Journal Article